Notably, the relative importance of these mechanisms may vary by cancer type and sex; for example, estrogen-related hormonal pathways play a larger role in female-predominant cancers such as breast and uterine cancer, whereas insulin resistance and visceral adiposity may be more relevant to cancers more common in males, such as liver and colorectal cancer. This evidence concerns the gene INS and uterine cancer.